AFP	Alpha-fetoprotein
APC	Adenomatous Polyposis Coli
BCLC	Barcelona Clinic Liver Cancer
CNA	Copy number alteration
cfDI	Cell-free DNA integrity
ccfDNA	Circulating Cell-free DNA
CFRT	Conventionally fractionated RT
CNVs	Copy-number variants
CTCs	Circulating tumor cells
ctDNA	Circulating tumor DNA
CTLA4	Cytotoxic T-lymphocyte antigen 4
CTNNB1	Catenin beta 1
DCR	Disease control rate
DFS	Disease free survival
DNMT	DNA methyltransferase
EGFR	Epidermal growth factor receptor
ESC	Embryonic stem cells
GIN	Genome-instability
GSTP1	Glutathione S-transferase P1
HBV	Hepatitis B virus
HCC	Hepatocellular carcinoma
HCV	Hepatitis C virus
hTERT	Human telomerase reverse transcriptase
IHFF	Intrahepatic failure-free
KRAS	KRAS proto-oncogene GTPase
LC	Local control
MRD	Minimal residual disease
MSRE-PCR	Methylation-sensitive restriction enzyme digestion PCR
NGS	Next-generation sequencing
OS	Overall survival
PCR	Polymerase chain reaction
p16	Protein p16
PD-1	Programmed cell death protein-1
PD-L1	Programmed death-ligand 1
PFS	Progression-free survival
RASSF1A	Ras association domain family 1 isoform A
RT-CT	Radio-chemotherapy
SBRT	Stereotactic body radiation therapy;
SEPT9	Septin 9
SFRP1	Secreted frizzled related protein 1
SNVs	Single-nucleotide variants
SPINT2	Serine peptidase inhibitor, kunitz type 2
TACE	Transarterial chemoembolization
TFPI2	Tissue factor pathway inhibitor 2
TMB	Tumor mutational burden
TP53	Tumor protein p53
TTP	Time to progression
VEGFA	Vascular endothelial growth factor A
WES	Whole-exome sequencing
WGS	Whole-genome sequencing